Identification and validation of differential plasma diagnostic biomarkers of ovarian cancer based on lipidomics

Hong-yu XIE,Wen-jie WANG,Zhen-zi LI,Bai-rong XIA,Kang LI,Yan HOU

DOI: https://doi.org/10.16073/j.cnki.cjcpt.2016.23.006

2016-01-01

Abstract:OBJECTIVE Ovarian cancer is one of the most common gynecologic maligancies.About 90％ of ovarian cancer patients were diagnosed at an advanced stage (Ⅲ/Ⅳ).Despite improvements in mulitimodality treatment,the 5-year overall survival for advanced ovarian cancer is less than 20％,while patients recognized at early stage (Ⅰ / Ⅱ),the 5-year survival rates are more than 90％.This study aimed to identify the differential plasma lipids biomarkers to improve the accuracy of ovarian carcinoma diagnosis.METHODS We combined the results from multivariate sparse-group lasso method and univariate Wilcoxon rank sum test to identify the potentially differential lipids biomarkers of the plasma from 139 ovarian carcinoma and 76 benign tumor patients which collected from Department of Gynecology of Harbin Medical University Tumor Hospital between March 1,2011 and July 31,2013.We identified the biomarkers that are not related with CA125 and assessed the diagnostic accuracy of differential lipids and the combined diagnostic accuracy of those complementary biomarkers with CA125 using the 7-fold cross-validation method.In addition,cytoscape software was used to construct the network of these differential lipids to study the relationship of them.Finally,we identified the differential lipids biomarkers to distinguish early-stage from late-stage patients.RESULTS We identified 20 differential lipids between ovarian cancer and controls,of which Stearamide,Stearic acid,Arachidic acid,PI(42 ∶ 9) were not related with CA125 (P＜0.05),the AUC value of the combination of these lipids with CA125 was 0.94,which was larger than that with CA125 alone.Of the 20 lipids,8 lipids were selected as potential biomarkers to distinguish those early-stage from late-stage patients,they are PC(35∶4),PC(38 ∶ 6),PC(46 ∶ 4),PC(P-35 ∶ 2),PE(P-36 ∶ 6),PG(34 ∶ 2),Cer (d18 ∶ 1/16 ∶ 0),3-Deoxyvitamin D3,respectively,and all P＜0.05.CONCLUSIONS Studying on the plasma lipidomics of ovarian cancer has improved the diagnostic accuracy of CA125 alone.Eight biomarkers could be used for early diagnosis of ovarian carcinoma.These results should be further validated in a large prospective cohort study.